product summary
Loading...
company name :
R&D Systems
product type :
ELISA/assay
product name :
Human MMP-8 Magnetic Luminex® Performance Assay
catalog :
LMPM908
quantity :
1 Kit
price :
200 USD
more info or order :
citations: 3
Reference |
---|
Albuquerque V, Kumar N, Fukutani K, Vasconcelos B, Arriaga M, Silveira Mattos P, et al. Plasma levels of C-reactive protein, matrix metalloproteinase-7 and lipopolysaccharide-binding protein distinguish active pulmonary or extrapulmonary tuberculosis from uninfected controls in children. Cytokine. 2019;123:154773 pubmed publisher
|
image
image 1 :

product information
master code :
LMPM908
SKU :
LMPM908
product name :
Human MMP-8 Magnetic Luminex® Performance Assay
unit size :
1 Kit
target :
MMP-8
category :
Luminex Assays
species :
Human
gene symbol :
MMP8
url print :
?utm_source=labome&utm_medium=referral&utm_campaign=product&utm_term=luminexassays
kit type :
Magnetic bead-based multiplex assay for the Luminex MAGPIX platform
elisaSampleTypes :
Cell Culture Supernates (10 uL), Serum (10 uL), Heparin Plasma (10 uL), Platelet-poor Heparin Plasma (10 uL), Saliva (10 uL), Urine (10 uL)
USD :
200 USD
alt names :
CLG1HNC, Collagenase 2, EC 3.4.24, EC 3.4.24.34, matrix metallopeptidase 8 (neutrophil collagenase), matrix metalloproteinase 8 (neutrophil collagenase), Matrix metalloproteinase-8, MMP8, MMP-8, neutrophil collagenase, PMNL collagenase, PMNL-CL
storage :
Store the unopened product at 2 - 8 ░C. Do not use past expiration date.
more info or order :
company information

R&D Systems
614 McKinley Place N.E.
Minneapolis, MN 55413
Minneapolis, MN 55413
info@RnDSystems.com
https://www.rndsystems.com800 343-7475
headquarters: USA
R&D Systems develops and manufactures high-quality proteins and serves as a world leader in immunoassays. R&D Systems also produces quality antibodies, antibody arrays, stem cell and cell culture products, and cell selection and detection products, serving the life science and diagnostics industry.
related products
browse more products
questions and comments